Purpose: To evaluate visual acuity, refractive outcomes, and endothelial cell density 6 months after Descemet stripping and automated endothelial keratoplasty (DSAEK).
D escemet stripping and automated endothelial keratoplasty (DSAEK) is a form of lamellar corneal surgery that allows for the selective replacement of diseased endothelium. 1 It represents a modification of posterior lamellar keratoplasty (PLK) introduced by Melles et al 2 and refined by Terry and Ousley 3, 4 as deep lamellar endothelial keratoplasty (DLEK), by Price and Price 1 as Descemet stripping and endothelial keratoplasty, and by Gorovoy 5 as Descemet stripping and automated endothelial keratoplasty (DSAEK). This technique uses a microkeratome to harvest a posterior lamellar corneal lenticule from the donor cornea. The folded donor corneal lenticule is inserted into the host anterior chamber through a small limbal incision (5 mm or less) and unfolded and positioned against the host stromal surface by using an air bubble. The advantages of all forms of PLK include rapid visual rehabilitation, minimal induced astigmatism, and a predictable change in corneal power postoperatively. However, the long-term survival of the grafted donor lenticule in DSAEK is unknown. The purpose of this study was to assess visual acuity, refractive outcomes, and endothelial cell density 6 months after our initial cases of DSAEK.
MATERIALS AND METHODS
This study includes 34 consecutive patients, 26 from the Eye Institute at the Medical College of Wisconsin (clinical site A) and 8 from the Cole Eye Institute at the Cleveland Clinic (clinical site B), with corneal edema from Fuchs endothelial dystrophy, pseudophakic bullous keratopathy, or aphakic bullous keratopathy who underwent DSAEK. These patients represent our initial experience with DSAEK at each institution, although 1 surgeon had prior experience with 23 cases of DLEK (SBK). This prospective study was approved by the institutional review boards of each respective institution, and all patients received informed consent and signed an investigational surgical protocol and surgical consent form. The study began in March 2005 and recruitment is ongoing. Preoperatively, all patients underwent a complete ophthalmologic examination including uncorrected Snellen visual acuity, spectacle visual acuity, manifest refraction whenever possible, slit-lamp examination, measurement of intraocular pressure with a pneumotonometer, and a dilated fundus examination. In addition, patients underwent corneal topography (Zeiss Humphrey Systems Atlas Version A11.2, Dublin, CA) and measurement of central corneal thickness with ultrasonic pachymetry (Micropach 200P+; Sonomed, Lake Success, NY). Specular microscopy of the donor corneal endothelium was performed using a Konan Eye Bank KeratoAnalyzer specular microscope (Konan Medical Corp., Fair Lawn, NJ) at the Wisconsin Lions Eye Bank or a Hai EB-3000XYZ specular microscope (Hai Laboratories, Lexington, MA) at the Cleveland Eye Bank. Postoperatively, all patients underwent similar measurements at 1, 3, and 6 months. In addition, endothelial cell density was measured 6 months after surgery with noncontact specular microscopy (Noncon Robo SP6000; Konan Medical Corp.). All patients described in this report reached the 6-month follow-up interval.
At each institution, surgery was performed by a single surgeon (SBK or DMM) beginning in March 2005. Surgery was performed under general or monitored local anesthesia. The donor corneal lenticule was prepared from the donor cornea and its scleral rim by using a Moria ALTK or CB microkeratome head with 300-mm-depth blade and a Moria artificial anterior chamber maintainer (Moria, Doyleston, PA) filled with balanced salt solution (BSS; Alcon, Fort Worth, TX) at clinical site A and air at clinical site B. After excision of the anterior corneal lamella, the posterior lamellar tissue was punched from the endothelial side by using an 8.5-mm Barron-Hessburg trephine (Katena, Danville, NJ) in all cases except one, in which a 9.0-mm trephine was used. The donor corneal lenticule remained covered by Optisol Solution (Chiron Ophthalmics, Irvine, CA) until use.
A clear corneal temporal incision was made in the host with a 2.75-or 3.0-mm keratome. In patients undergoing a triple procedure (combined keratoplasty, cataract extraction, and intraocular lens placement), surgery was performed through the same incision by using phacoemulsification and a ''divide and conquer'' technique to remove the nucleus. The host epithelium was marked with an 8.5-mm, or in 1 case a 9.0-mm, Weck trephine (Solan Medtronics, Jacksonville, FL) stained with gentian violet dye. In almost all cases, the anterior chamber was filled with viscoelastic (Healon; Advanced Medical Optics, Santa Ana, CA or ViscCoat; Alcon), and a Price-Sinsky hook (Asko, Westmont, IL) was used to incise the host endothelium and Descemet membrane along the circumference corresponding to the epithelial trephine mark. A Melles stripper (DORC, Zuidland, Netherlands), sometimes in combination with an aspirating handpiece, was used to carefully remove diseased host endothelium and Descemet membrane from within the circumference of the Descemet incision. The specimen was submitted for pathologic examination. Viscoelastic was carefully removed using a 0.3-mm tip of the irritation-aspiration instrument of the Alcon Legacy 2000 phacoemulsification unit (Alcon). The clear corneal incision was widened to 4.2-5 mm by using a keratome or short cut blade. A subset of patients received surgical iridectomies in the peripheral iris by using Vannas scissors.
The donor lenticule that had been previously prepared was transferred to the surgical field, endothelial side up. The endothelial surface of the donor lenticule was coated with a small amount of viscoelastic and gently folded into a ''taco'' shape by using Utrata (Bausch & Lomb Storz, San Dimas, CA) or Kelman-McPherson forceps (Katena, Danville, NJ). The folded donor corneal lenticule was gently grasped at the leading edge and placed into the anterior chamber. A 5-mL syringe of BSS (Alcon) with a 30-gauge cannula was used to unfold the donor corneal lenticule. The graft was centered with a barbed 30-gauge needle that was used to engage the edge of the graft. The anterior chamber was filled with air to moderate tactile tension by using an air cannula for 7-10 minutes, after which time ;40% of the air bubble was removed and replaced with BSS. The technique used in this pilot study followed the institutional review board protocol that was submitted in 2004. It did not include the use of corneal stab incisions or peripheral posterior stromal scraping-techniques that have been proposed to improve lenticule adherence. 1 At the conclusion of the case, patients received topical antibiotic and cycloplegic medications. Postoperatively, patients received topical antibiotics and cycloplegia for 1 week and topical prednisolone acetate 3 or 4 times a day for 1 month. After 1 month, the topical prednisolone was gradually tapered over a 3-month period and either discontinued or maintained, at most, at twicedaily dosing.
Statistical analyses were performed with SPSS version 14.0 (SPSS, Chicago, IL). Pre-and postoperative comparisons of logMAR visual acuity, spherical equivalent refractive error, magnitude of refractive astigmatism, and endothelial cell density were performed with paired-sample t tests at an a = 0.05 significance level. Comparisons of outcomes between patient subgroups were performed using the independentsample t test.
RESULTS
In total, 34 eyes of 34 patients underwent DSAEK either alone or in combination with phacoemulsification and posterior chamber intraocular lens insertion. Data on patient age, coexisting ocular morbidities, and preoperative clinical characteristics are shown in Table 1 .
The average preoperative best spectacle-corrected visual acuity (BSCVA) was 20/99 6 3.76 lines (range 20/40 to count fingers at 1 ft; Table 2 ). Two patients with 20/40 preoperative acuity had Fuchs endothelial dystrophy with bullae, foreign-body sensation, and diurnal fluctuation in vision. No attempt was made to measure their vision in the early morning. The average 6-month postoperative BSCVA was 20/42 6 2.25 lines (range, 20/20 to 20/200; Table 3 ).
After DSAEK, 30 (88.2%) of 34 patients showed improved BSCVA. Twenty-one (61.8%) of the 34 patients achieved a BSCVA of 20/40 or better. There was no statistical difference in 6-month postoperative BSCVA between eyes from clinical site A and those from clinical site B (P = 0.26), between eyes undergoing triple procedures (n = 11) and those undergoing simple DSAEK (P = 0.25), between those experiencing an episode of graft rejection (n = 6) and those without an episode of graft rejection (P = 0.36), or between those who underwent successful repositioning of the donor lenticule (n = 6) and those who did not require repositioning (P = 0.94).
The average preoperative spherical equivalent refractive error was 20.062 6 2.67 D (range, 28.00 to 6.38) compared with +0.974 6 1.85 D (range, 21.75 to +6.38 D) postoperatively (P = 0.0003; n = 23; Table 3 ). This comparison excluded patients undergoing simultaneous cataract extraction and intraocular lens implantation because emmetropia or mild myopia was typically targeted as the desired postoperative refraction. In patients who underwent simple DSAEK without phacoemulsification and intraocular lens implantation, an average hyperopic shift in refraction of 1.19 6 1.32 D was found at 6 months. The average preoperative refractive astigmatism measured 1.68 6 1.22 D (range, 0-5.00 D) compared with 1.80 6 1.11 D (range, 0.0-5.75) post-operatively (P = 0.46). Because of epithelial bullae and corneal epithelial edema, only 12 patients had measurable preoperative corneal topography, and there was no statistically significant difference between pre-and postoperative topographic astigmatism (P = 0.59). Preoperative average keratometry measured 43.5 6 2.03 D (range, 39.9-47.0 D) compared with 42.8 6 1.73 (range, 39.9-46.0 D) postoperatively (n = 14; P = 0.16). Preoperative ultrasonic pachymetry was performed on 25 patients and averaged 729 6 83.2 mm (range, 615-935 mm). All donor grafts and host corneal stroma appeared optically clear and compact and preoperative epithelial bullae resolved.
Preoperative endothelial cell density performed on donor corneal tissue by the eye banks averaged 2826 6 370 cells/mm 2 (range, 2000-3787 cells/mm 2 ; Table 4 ). The average postoperative donor endothelial cell density was 1396 6 440 cells/mm 2 (range, 645-2513 cells/mm 2 ) in 30 eyes in which specular microscopy was performed at 6 months (P = 0.0001). This finding represents an average loss of 1426 cells/mm 2 (range, 760-2973 cells/mm 2 ) and an average percent cell loss of 50.4% (range, 24%-79%). There was no statistical difference in the decrease in endothelial cell density between eyes undergoing DSAEK at clinical site A versus clinical site B (P = 0.09), between eyes undergoing triple procedures (n = 11) versus those undergoing simple DSAEK (P = 0.54), or between eyes undergoing successful lenticule repositioning (n = 6) and those not requiring repositioning (P = 0.72). Eyes that experienced an episode of acute graft rejection had an average cell loss of 1677 6 912 *These values represent the mean of each eye's cell loss (n = 30) so will not be the simple difference between the first and second columns, as n = 34 in the first column.
†t test comparing endothelial cell loss between sites A and B. ‡Paired-sample t test comparing pre-to postoperative endothelial cell density for eyes with both values known (n = 30). g cells/mm 2 (range, 902-2973 cells/mm 2 ) compared with 1388 6 430 cells/mm 2 (range, 760-2341 cells/mm 2 ) in eyes that did not experience an episode of graft rejection (P = 0.30). When both centers were analyzed together, cell loss averaged 1674 cells/mm 2 (59% cell loss) in the first half of cases compared with 1181 cells/mm 2 (41% cell loss) in the second half of cases (P = 0.005; Table 5 ).
Nine eyes (26.5%) of 34 patients experienced separation of the donor corneal lenticule from the host stroma on the first postoperative day. Each of these patients underwent repositioning of the donor graft with an air bubble between day 1 and day 7 postoperatively. Three of these dislocated donor lenticules remained dislocated, were considered iatrogenic surgery failures, and underwent repeat DSAEK with new donor corneal tissue. After repeat surgery, all grafts remained clear during the 6-month follow-up period. One patient experienced pupillary block glaucoma secondary to the anterior chamber air bubble despite the presence of a surgical peripheral iridectomy and postoperative cycloplegia.
Six patients (17.6%) developed acute graft rejection characterized by an endothelial rejection line and keratic precipitates on the donor endothelium. Five of these cases (5/26; 19.2%) occurred at clinical site A, and one (1/8; 12.5%) occurred at site B. In each case, the graft rejection was successfully treated with intensive topical corticosteroids. Routine topical steroid use at 6 months varied between clinical sites. At site A, patients were tapered off steroids routinely by 4 months (4 times daily for 1 month, followed by 3 times daily for 1 month, followed by 2 times daily for 1 month, followed by 1 time daily for 1 month). Therefore, the only patients on topical steroids at the 6-month visit would be those with current graft rejection or those being tapered off topical steroids because of a recent episode of rejection. At site B, patients were routinely maintained on twice-daily dosing of topical steroids through the 6-month postoperative visit.
DISCUSSION
From our experience, DSAEK seems to be an effective procedure for replacing diseased corneal endothelium. The results of this series indicate that DSAEK provides 6-month postoperative visual acuity that is comparable to that of DLEK and better than that of standard penetrating keratoplasty in patients with pseudophakic bullous keratopathy, Fuchs dystrophy, and aphakic bullous keratopathy. 4, 6 Although 1 patient in our series achieved 20/20 vision, the average 6-month postoperative BSCVA in our series of patients was 20/42. This average BSCVA is similar to a previous report of DLEK by Terry and Ousley 4 and to 1-year results in a recent series of DSAEK patients reported by Gorovoy. 5 In our series, all donor corneal lenticules remained clear at 6 months, 88.2% of eyes showed improved BSCVA, and 61.8% of eyes had a BSCVA of 20/40 or better. These results are comparable to the 6-month results published by Price and Price, 7 in which BSCVA equaled or exceeded 20/40 in 69% of eyes with microkeratome-prepared lenticules and 55% of eyes with manually prepared lenticules. Moreover, there were no statistically significant changes in refractive astigmatism in our series or in that of Price and Price. 7 Although we observed a significant tendency toward hyperopic shift, Price and Price 7 observed smaller hyperopic shifts (averaging 0.50 D), and only in the manually dissected donor group.
We are concerned about the significant loss of donor endothelial cells postoperatively and its potential implications for long-term graft survival. In this series of DSAEK, the average donor endothelial cell count fell from a preoperative density of 2826 6 370 to 1396 6 440 cells/mm 2 . In contrast, Melles et al 8 recorded an average donor lenticule endothelial cell density of 2366 6 357 cells/mm 2 6 months after largeincision DLEK in 11 eyes. He used a viscoelastic-coated spoon-shaped glide to insert an unfolded 7.0-to 8.0-mmdiameter donor lenticule through a 9.0-mm corneoscleral pocket incision. 8 Similarly, Terry and Ousley 9 found an average endothelial cell count of 2335 6 468 cells/mm 2 1 year after insertion of 7.5-to 8.0-mm-diameter donor lenticules by using a similar large-incision (9.0-9.5 mm) technique in 20 eyes. In contrast, for the 4 eyes in which Melles et al folded and inserted larger donor corneal lenticules (8.5-9.0 mm in diameter) through smaller (5.0 mm) scleral tunnel incisions, the endothelial cell count fell to 1535 6 322 cells/mm 2 6 months after surgery. This finding represents a nearly 43% decline. 8 Melles attributed the postoperative decrease in donor endothelial cell density to the trauma of inserting folded donor tissue into the eye. 8 Although not strictly comparable, our results agree closely with the findings of Melles et al and differ significantly from those of Terry and Ousley, who found an average 6-month postoperative cell count of 2112 6 420 (25% loss) by using a small-incision DLEK procedure in a larger series 62 eyes. 4 In addition, Terry and Ousley 4 reported that, in 36 eyes with large-incision DLEK when using unfolded tissue, the endothelial cell loss (23%) was not statistically different at 6 months from that in the small-incision DLEK cases (25%). Gorovoy 5 reported a mean 40% decline in endothelial cell counts over a mean follow-up of 10 months with the DSAEK technique. Although our overall cell loss at 6 months was higher (50.4%), it was comparable to those reported by Gorovoy in the latter half of our cases as described below. In our study, topical steroids were tapered relatively quickly compared with some other surgeons' protocols, and our observed endothelial cell attrition in some eyes may have been higher because of subclinical chronic low-grade inflammation or rejection.
In contrast to traditional penetrating keratoplasty and large-incision DLEK cases, DSAEK uses a microkeratome and artificial anterior chamber to harvest the corneal lenticule from the cornea and its scleral rim. 1 Furthermore, the donor lenticule is folded into a ''taco'' shape and inserted into a shallow host anterior chamber through a small (4.2-5 mm) corneal incision. The lenticule is unfolded, positioned by engaging the peripheral donor endothelium, and held in apposition to the host stroma with a large anterior chamber air bubble. During each step of the aformentioned procedure, the donor endothelium may suffer mechanical trauma not ordinarily encountered during standard penetrating keratoplasty or even large-incision DLEK. Other potential sources of endothelial cell trauma include harvesting the corneal lenticule under high pressures on the artificial anterior chamber, compression of endothelial cells by forceps during folding, inadvertent contact between the donor endothelium and the lens-iris diaphragm during lenticule insertion, or prolonged contact with an air bubble under elevated intraocular pressure. 10 Furthermore, manipulation of the donor lenticule with a barbed needle causes direct mechanical trauma to peripheral donor endothelial cells. Further clouding the issue is the fact that the comparison of postoperative endothelial cell density to eye bank specular microscopy counts merely estimated iatrogenic cell loss; cell loss can occur during storage as a function of preservationto-surgery time independent of the trauma of donor tissue insertion. Although we typically use an 8.5-mm-diameter donor lenticule with more donor endothelial cells on average than a standard 8.0-mm penetrating keratoplasty button, endothelial cell losses on the order of those reported here may contribute to premature graft failure. The lower endothelial cell counts seen in our series of patients may also represent the ''learning curve'' associated with this new surgical technique. This is particularly apparent when considering that the average endothelial cell loss of the first half of our cases was 1674 cells/mm 2 (59% cell loss) compared with 1181 cells/mm 2 (41.0% cell loss) for the second half (P = 0.005; Table 5 ).
Six patients (17.6%) experienced acute endothelial rejection episodes that were reversed with topical corticosteroid therapy. Although we do not know the incidence of rejection in our own patients undergoing penetrating keratoplasty, it is our clinical impression that this figure is higher in patients undergoing DSAEK. Our postoperative practice is to treat low-risk penetrating keratoplasty patients with prednisolone 1% drops 4 times daily for a month and gradually taper the steroids over the following 3-month period. Similarly, Bourne 11 rapidly tapered topical prednisolone acetate over a 3-to 6-month period, rarely using steroids more than once daily after the second month. In their series, the cumulative risk of rejection at 10 years was 21%, and the rate of postoperative endothelial cell loss was 34% at 1 year. 11 Although acute endothelial rejection has been associated with postkeratoplasty endothelial cell loss, 2 studies found no difference in endothelial cell density in grafts with previous rejection episodes. 11, 12 Examination of our patients with acute graft rejection showed no significant difference in endothelial cell loss at 6 months compared with those patients without a rejection episode (P = 0.30)-this subgroup was small, and in retrospective analysis, this comparison was powered to detect only a difference of 895 cells/mm 2 with a type I (a) error of 0.05 and a type II error (b) of 0.20.
As with penetrating keratoplasty, the long-term success of DSAEK will depend on an adequate number of viable endothelial cells in the donor corneal lenticule. 9 Ing et al 11 found that the most common cause of late-failing penetrating keratoplasty was low endothelial cell counts, attributed to possible chronic subclinical graft rejection, persistent lowgrade inflammation, or donor-host endothelial interaction. In patients undergoing DSAEK, it is unclear whether the increased number of donor endothelial cells associated with a larger donor graft (8.5-9.0 mm) will offset the rate of endothelial cell loss or migration. It is also uncertain whether the increased thickness of the cornea (average, 695 6 57 mm) after the addition of a posterior lamellar graft will affect the ability of the remaining endothelial cells to adequately dehydrate the corneal stroma. However, we feel that concerns about the long-term survival of the donor lenticule after DSAEK are offset by the rapid visual recovery, low morbidity, and minimal effect on anterior corneal curvature.
In summary, this study of 6-month outcomes after DSAEK shows rapid postoperative visual improvement with only a mild hyperopic refractive shift in the spherical equivalent and no significant induced astigmatism. An overall improvement in average BSCVA was also observed. Postoperative complications were treatable and included donor lenticule dislocation, iatrogenic donor failure, endothelial graft rejection, and pupillary block glaucoma. Most of these complications, and a significant loss of donor endothelial cells, seem to be related to surgical experience and the steep learning curve associated with this procedure. Although the long-term results of DSAEK remain unknown, its inherent advantages make it an attractive alternative to penetrating keratoplasty for patients with endothelial disease.
